Cargando…

Development and Validation of a Fetal Cardiovascular Disease Severity Scale

Prenatal heart disease spans the spectrum of severity from very mild to severe life-threatening conditions. An accepted scale for grading fetal cardiovascular disease severity would aid in anomaly standardization, counseling, and future research. The Fetal Cardiovascular Disease Severity Scale with...

Descripción completa

Detalles Bibliográficos
Autores principales: Davey, Brooke T., Donofrio, Mary T., Moon-Grady, Anita J., Fifer, Carlen G., Cuneo, Bettina F., Falkensammer, Christine B., Szwast, Anita L., Rychik, Jack
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4164841/
https://www.ncbi.nlm.nih.gov/pubmed/24801674
http://dx.doi.org/10.1007/s00246-014-0911-9
_version_ 1782335018249486336
author Davey, Brooke T.
Donofrio, Mary T.
Moon-Grady, Anita J.
Fifer, Carlen G.
Cuneo, Bettina F.
Falkensammer, Christine B.
Szwast, Anita L.
Rychik, Jack
author_facet Davey, Brooke T.
Donofrio, Mary T.
Moon-Grady, Anita J.
Fifer, Carlen G.
Cuneo, Bettina F.
Falkensammer, Christine B.
Szwast, Anita L.
Rychik, Jack
author_sort Davey, Brooke T.
collection PubMed
description Prenatal heart disease spans the spectrum of severity from very mild to severe life-threatening conditions. An accepted scale for grading fetal cardiovascular disease severity would aid in anomaly standardization, counseling, and future research. The Fetal Cardiovascular Disease Severity Scale with seven severity grades ranging from mild (grade 1) to severe (grade 7) disease was developed. Severity grade relates to the cardiovascular condition diagnosed by fetal echocardiography, with factors including postnatal intervention, number of interventions anticipated, likelihood of two-ventricle repair versus single-ventricle palliation, and overall prognosis. A survey describing 25 cardiac anomalies was offered to fetal cardiologists at six institutions for validation of scale reliability among practitioners. The study participants graded defects using this scale. A smaller group graded anomalies again more than 2 weeks after the initial survey. The intraclass correlation coefficient (ICC) was used to assess agreement of the respondents. The survey participants were 14 experienced fetal cardiologists: 9 from the Children’s Hospital of Philadelphia (CHOP) and 5 from five additional institutions in the United States. The initial survey ICC was high [0.93; 95 % confidence interval (CI) 0.88–0.96]. The subanalysis showed a higher ICC for the participants outside CHOP (0.95; 95 % CI 0.91–0.98 vs. 0.92; 95 % CI 0.86–0.96, respectively). The ICCs were high for all the fetal cardiologists participating in the repeat evaluation, ranging from 0.92 to 0.99 (95 % CI 0.65–1.00). The Fetal Cardiovascular Disease Severity Scale demonstrated good inter- and intrarater reliability among experienced fetal cardiologists and is a valid tool for standardization of prenatal cardiac diagnostic assessment across institutions. The scale has applications for parental counseling and research in fetal cardiovascular disease.
format Online
Article
Text
id pubmed-4164841
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Springer US
record_format MEDLINE/PubMed
spelling pubmed-41648412014-09-18 Development and Validation of a Fetal Cardiovascular Disease Severity Scale Davey, Brooke T. Donofrio, Mary T. Moon-Grady, Anita J. Fifer, Carlen G. Cuneo, Bettina F. Falkensammer, Christine B. Szwast, Anita L. Rychik, Jack Pediatr Cardiol Original Article Prenatal heart disease spans the spectrum of severity from very mild to severe life-threatening conditions. An accepted scale for grading fetal cardiovascular disease severity would aid in anomaly standardization, counseling, and future research. The Fetal Cardiovascular Disease Severity Scale with seven severity grades ranging from mild (grade 1) to severe (grade 7) disease was developed. Severity grade relates to the cardiovascular condition diagnosed by fetal echocardiography, with factors including postnatal intervention, number of interventions anticipated, likelihood of two-ventricle repair versus single-ventricle palliation, and overall prognosis. A survey describing 25 cardiac anomalies was offered to fetal cardiologists at six institutions for validation of scale reliability among practitioners. The study participants graded defects using this scale. A smaller group graded anomalies again more than 2 weeks after the initial survey. The intraclass correlation coefficient (ICC) was used to assess agreement of the respondents. The survey participants were 14 experienced fetal cardiologists: 9 from the Children’s Hospital of Philadelphia (CHOP) and 5 from five additional institutions in the United States. The initial survey ICC was high [0.93; 95 % confidence interval (CI) 0.88–0.96]. The subanalysis showed a higher ICC for the participants outside CHOP (0.95; 95 % CI 0.91–0.98 vs. 0.92; 95 % CI 0.86–0.96, respectively). The ICCs were high for all the fetal cardiologists participating in the repeat evaluation, ranging from 0.92 to 0.99 (95 % CI 0.65–1.00). The Fetal Cardiovascular Disease Severity Scale demonstrated good inter- and intrarater reliability among experienced fetal cardiologists and is a valid tool for standardization of prenatal cardiac diagnostic assessment across institutions. The scale has applications for parental counseling and research in fetal cardiovascular disease. Springer US 2014-05-07 2014 /pmc/articles/PMC4164841/ /pubmed/24801674 http://dx.doi.org/10.1007/s00246-014-0911-9 Text en © The Author(s) 2014 https://creativecommons.org/licenses/by/4.0/ Open AccessThis article is distributed under the terms of the Creative Commons Attribution License which permits any use, distribution, and reproduction in any medium, provided the original author(s) and the source are credited.
spellingShingle Original Article
Davey, Brooke T.
Donofrio, Mary T.
Moon-Grady, Anita J.
Fifer, Carlen G.
Cuneo, Bettina F.
Falkensammer, Christine B.
Szwast, Anita L.
Rychik, Jack
Development and Validation of a Fetal Cardiovascular Disease Severity Scale
title Development and Validation of a Fetal Cardiovascular Disease Severity Scale
title_full Development and Validation of a Fetal Cardiovascular Disease Severity Scale
title_fullStr Development and Validation of a Fetal Cardiovascular Disease Severity Scale
title_full_unstemmed Development and Validation of a Fetal Cardiovascular Disease Severity Scale
title_short Development and Validation of a Fetal Cardiovascular Disease Severity Scale
title_sort development and validation of a fetal cardiovascular disease severity scale
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4164841/
https://www.ncbi.nlm.nih.gov/pubmed/24801674
http://dx.doi.org/10.1007/s00246-014-0911-9
work_keys_str_mv AT daveybrooket developmentandvalidationofafetalcardiovasculardiseaseseverityscale
AT donofriomaryt developmentandvalidationofafetalcardiovasculardiseaseseverityscale
AT moongradyanitaj developmentandvalidationofafetalcardiovasculardiseaseseverityscale
AT fifercarleng developmentandvalidationofafetalcardiovasculardiseaseseverityscale
AT cuneobettinaf developmentandvalidationofafetalcardiovasculardiseaseseverityscale
AT falkensammerchristineb developmentandvalidationofafetalcardiovasculardiseaseseverityscale
AT szwastanital developmentandvalidationofafetalcardiovasculardiseaseseverityscale
AT rychikjack developmentandvalidationofafetalcardiovasculardiseaseseverityscale